SG11202002692XA - Azabicyclo and diazepine derivatives for treating ocular disorders - Google Patents
Azabicyclo and diazepine derivatives for treating ocular disordersInfo
- Publication number
- SG11202002692XA SG11202002692XA SG11202002692XA SG11202002692XA SG11202002692XA SG 11202002692X A SG11202002692X A SG 11202002692XA SG 11202002692X A SG11202002692X A SG 11202002692XA SG 11202002692X A SG11202002692X A SG 11202002692XA SG 11202002692X A SG11202002692X A SG 11202002692XA
- Authority
- SG
- Singapore
- Prior art keywords
- azabicyclo
- ocular disorders
- treating ocular
- diazepine derivatives
- diazepine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762581073P | 2017-11-03 | 2017-11-03 | |
| US201862749610P | 2018-10-23 | 2018-10-23 | |
| PCT/IB2018/058631 WO2019087146A1 (en) | 2017-11-03 | 2018-11-02 | Azabicyclo and diazepine derivatives for treating ocular disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202002692XA true SG11202002692XA (en) | 2020-05-28 |
Family
ID=64267873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202002692XA SG11202002692XA (en) | 2017-11-03 | 2018-11-02 | Azabicyclo and diazepine derivatives for treating ocular disorders |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11306090B2 (en) |
| EP (1) | EP3704117A1 (en) |
| JP (3) | JP7065180B2 (en) |
| KR (1) | KR20200083976A (en) |
| CN (1) | CN111247147A (en) |
| AU (3) | AU2018362010B2 (en) |
| BR (1) | BR112020007744A2 (en) |
| CA (2) | CA3076457C (en) |
| MX (2) | MX2020004580A (en) |
| SG (1) | SG11202002692XA (en) |
| TW (1) | TWI826399B (en) |
| WO (2) | WO2019087146A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102534570B1 (en) * | 2019-02-01 | 2023-05-18 | 에어리 파마슈티컬즈, 인코포레이티드 | Compounds, compositions and methods for the treatment of myopia |
| US20240099970A1 (en) * | 2022-09-11 | 2024-03-28 | Alcon Inc. | Aqueous pharmaceutical compositions comprising benzyl atropine and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1165037B (en) * | 1961-11-21 | 1964-03-12 | Dr. Schwarz Arzneimittelfabrik G.m.b.H., Monheim (RhId.) | Process for the preparation of esters of quaternary atropinium salts. |
| GB994493A (en) * | 1963-02-06 | 1965-06-10 | Lepetit Spa | Tropine derivative |
| DE1670177A1 (en) * | 1966-12-28 | 1970-11-12 | Boehringer Sohn Ingelheim | Process for the preparation of new N-substituted noratropinium salts |
| US5223528A (en) * | 1986-03-17 | 1993-06-29 | University Of Florida | Anticholinergic compounds, composititons and methods of treatment |
| NZ529615A (en) * | 2001-05-25 | 2005-07-29 | Valley Forge Pharmaceuticals | Pirenzepine ophthalmic gel |
| FR2834511B1 (en) | 2002-01-07 | 2004-02-13 | Sanofi Synthelabo | DERIVATIVES OF 5- (PYRIDIN-3-YL) -1-AZABICYCLO [3.2.1] OCTANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
| CN1546490A (en) | 2003-12-15 | 2004-11-17 | 常俊标 | Asymmetric dihydroxyltropine alkaloids , their preparing process and pharmaceutical use |
| CN1283639C (en) | 2004-06-08 | 2006-11-08 | 吴建梅 | Pirenzepine organic acid salt and eye drops for treating myopia |
| US20070254914A1 (en) * | 2006-05-01 | 2007-11-01 | Non-Profit Organization Chang Gung Memorial Hospital | Low-concentration atropine solution for preventing myopia progression and preparing method thereof |
| SG10201510576WA (en) | 2010-12-22 | 2016-01-28 | Meiji Seika Pharma Co Ltd | Optically active diazabicyclooctane derivative and process for preparing the same |
-
2018
- 2018-11-02 WO PCT/IB2018/058631 patent/WO2019087146A1/en active Application Filing
- 2018-11-02 CA CA3076457A patent/CA3076457C/en active Active
- 2018-11-02 JP JP2020520577A patent/JP7065180B2/en active Active
- 2018-11-02 US US16/760,192 patent/US11306090B2/en active Active
- 2018-11-02 EP EP18800336.2A patent/EP3704117A1/en active Pending
- 2018-11-02 WO PCT/IB2018/058637 patent/WO2019087149A1/en active Application Filing
- 2018-11-02 AU AU2018362010A patent/AU2018362010B2/en active Active
- 2018-11-02 MX MX2020004580A patent/MX2020004580A/en unknown
- 2018-11-02 CA CA3205816A patent/CA3205816A1/en active Pending
- 2018-11-02 SG SG11202002692XA patent/SG11202002692XA/en unknown
- 2018-11-02 CN CN201880068606.5A patent/CN111247147A/en active Pending
- 2018-11-02 KR KR1020207010292A patent/KR20200083976A/en active Search and Examination
- 2018-11-02 TW TW107138927A patent/TWI826399B/en active
- 2018-11-02 BR BR112020007744-5A patent/BR112020007744A2/en unknown
-
2020
- 2020-07-13 MX MX2022011310A patent/MX2022011310A/en unknown
-
2021
- 2021-07-16 AU AU2021205100A patent/AU2021205100B2/en active Active
-
2022
- 2022-03-21 US US17/699,606 patent/US11884666B2/en active Active
- 2022-04-25 JP JP2022071400A patent/JP2022101654A/en active Pending
-
2023
- 2023-04-03 AU AU2023202036A patent/AU2023202036A1/en active Pending
- 2023-11-30 US US18/524,807 patent/US20240132497A1/en active Pending
-
2024
- 2024-01-18 JP JP2024006023A patent/JP2024041971A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020536922A (en) | 2020-12-17 |
| US20240132497A1 (en) | 2024-04-25 |
| US11884666B2 (en) | 2024-01-30 |
| BR112020007744A2 (en) | 2020-10-13 |
| MX2020004580A (en) | 2020-12-03 |
| CA3076457A1 (en) | 2019-05-09 |
| EP3704117A1 (en) | 2020-09-09 |
| JP7065180B2 (en) | 2022-05-11 |
| KR20200083976A (en) | 2020-07-09 |
| WO2019087146A1 (en) | 2019-05-09 |
| US11306090B2 (en) | 2022-04-19 |
| AU2021205100A1 (en) | 2021-08-12 |
| JP2024041971A (en) | 2024-03-27 |
| JP2022101654A (en) | 2022-07-06 |
| AU2018362010B2 (en) | 2021-05-13 |
| US20220267328A1 (en) | 2022-08-25 |
| TW201922731A (en) | 2019-06-16 |
| CA3076457C (en) | 2023-09-19 |
| AU2021205100B2 (en) | 2023-01-05 |
| TWI826399B (en) | 2023-12-21 |
| WO2019087149A1 (en) | 2019-05-09 |
| MX2022011310A (en) | 2022-10-07 |
| AU2018362010A1 (en) | 2020-04-09 |
| AU2023202036A1 (en) | 2023-05-04 |
| CA3205816A1 (en) | 2019-05-09 |
| CN111247147A (en) | 2020-06-05 |
| US20210179616A1 (en) | 2021-06-17 |
| RU2020117733A (en) | 2021-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL249602A0 (en) | Methods and devices for treating posterior ocular disorders | |
| IL271085A (en) | Bacteria for the treatment of disorders | |
| HK1231417A1 (en) | Compounds for treating ophthalmic diseases and disorders | |
| EP3618829C0 (en) | Quinazoline-pyridine derivatives for the treatment of cancer-related disorders | |
| HRP20210518T1 (en) | 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders | |
| IL269174A (en) | Methods for treating complement-mediated diseases and disorders | |
| PL3634417T3 (en) | Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders | |
| GB201405232D0 (en) | Apparatus and methods for the treatment of ocular disorders | |
| ZA202002066B (en) | Compositions and methods for the treatment of eye disorders | |
| IL268357A (en) | Photoreceptor cells for the treatment of retinal diseases | |
| IL270114B1 (en) | Methods and compositions for treating neurological disorders | |
| IL267818A (en) | Methods for the treatment of neurological disorders | |
| IL267229A (en) | Methods of treating ocular disorders | |
| IL275654A (en) | Methods of treating disorders associated with castor | |
| IL275985A (en) | Compositions and methods for treating retinal disorders | |
| IL274378A (en) | Phosphorylcholine-tuftsin conjugate for treating ocular inflammation | |
| SG11202002692XA (en) | Azabicyclo and diazepine derivatives for treating ocular disorders | |
| EP3302684A4 (en) | Methods and devices for treating the cornea | |
| EP3200795A4 (en) | Use of agents for treating fat-related disorders | |
| ZA201806894B (en) | (+)-azasetron for use in the treatment of ear disorders | |
| PT3442537T (en) | (+)-azasetron for use in the treatment of ear disorders |